Home/ Stocks/ SEPN

Septerna, Inc. Common Stock

SEPN XNAS

$23.87 -0.11 (-0.46%) ▼ 15-min delayed

Open

$23.98

High

$24.86

Low

$23.82

Volume

208.4K

Market Cap

$1.07B

About Septerna, Inc. Common Stock

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 130 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$45.95M	$-48,879,000	$-1.10
FY 2025	$45.95M	$-48,879,000	$-1.10
Q3 2025	$21.50M	$8.17M	$0.18
Q2 2025	$119.0K	$-24,838,000	$-0.56

Related Market News

No specific coverage for SEPN yet. Check out our latest market news or earnings calendar.

Get SEPN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Septerna, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.